Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Hypertension Drug Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Hypertension Drug Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Calcium Channel Blockers
      • 1.3.3 Diuretics
      • 1.3.4 Beta Blockers Vasodilators
      • 1.3.5 Angiotensin Converting Enzyme Inhibitors
      • 1.3.6 Alpha Blockers
      • 1.3.7 Angiotensin Receptor Blockers
      • 1.3.8 Renin Inhibitors
    • 1.4 Market Segment by Application
      • 1.4.1 Global Hypertension Drug Market Share by Application (2019-2025)
      • 1.4.2 Hospital
      • 1.4.3 Private clinic
      • 1.4.4 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Hypertension Drug Market Size
      • 2.1.1 Global Hypertension Drug Revenue 2014-2025
      • 2.1.2 Global Hypertension Drug Sales 2014-2025
    • 2.2 Hypertension Drug Growth Rate by Regions
      • 2.2.1 Global Hypertension Drug Sales by Regions 2014-2019
      • 2.2.2 Global Hypertension Drug Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Hypertension Drug Sales by Manufacturers
      • 3.1.1 Hypertension Drug Sales by Manufacturers 2014-2019
      • 3.1.2 Hypertension Drug Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Hypertension Drug Revenue by Manufacturers (2014-2019)
      • 3.2.2 Hypertension Drug Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Hypertension Drug Market Concentration Ratio (CR5 and HHI)
    • 3.3 Hypertension Drug Price by Manufacturers
    • 3.4 Key Manufacturers Hypertension Drug Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Hypertension Drug Market
    • 3.6 Key Manufacturers Hypertension Drug Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Calcium Channel Blockers Sales and Revenue (2014-2019)
      • 4.1.2 Diuretics Sales and Revenue (2014-2019)
      • 4.1.3 Beta Blockers Vasodilators Sales and Revenue (2014-2019)
      • 4.1.4 Angiotensin Converting Enzyme Inhibitors Sales and Revenue (2014-2019)
      • 4.1.5 Alpha Blockers Sales and Revenue (2014-2019)
      • 4.1.6 Angiotensin Receptor Blockers Sales and Revenue (2014-2019)
      • 4.1.7 Renin Inhibitors Sales and Revenue (2014-2019)
    • 4.2 Global Hypertension Drug Sales Market Share by Type
    • 4.3 Global Hypertension Drug Revenue Market Share by Type
    • 4.4 Hypertension Drug Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Hypertension Drug Sales by Application

    6 United States

    • 6.1 United States Hypertension Drug Breakdown Data by Company
    • 6.2 United States Hypertension Drug Breakdown Data by Type
    • 6.3 United States Hypertension Drug Breakdown Data by Application

    7 European Union

    • 7.1 European Union Hypertension Drug Breakdown Data by Company
    • 7.2 European Union Hypertension Drug Breakdown Data by Type
    • 7.3 European Union Hypertension Drug Breakdown Data by Application

    8 China

    • 8.1 China Hypertension Drug Breakdown Data by Company
    • 8.2 China Hypertension Drug Breakdown Data by Type
    • 8.3 China Hypertension Drug Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Hypertension Drug Breakdown Data by Company
    • 9.2 Rest of World Hypertension Drug Breakdown Data by Type
    • 9.3 Rest of World Hypertension Drug Breakdown Data by Application
    • 9.4 Rest of World Hypertension Drug Breakdown Data by Countries
      • 9.4.1 Rest of World Hypertension Drug Sales by Countries
      • 9.4.2 Rest of World Hypertension Drug Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Lupin Limited
      • 10.1.1 Lupin Limited Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Hypertension Drug
      • 10.1.4 Hypertension Drug Product Introduction
      • 10.1.5 Lupin Limited Recent Development
    • 10.2 Novartis AG
      • 10.2.1 Novartis AG Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Hypertension Drug
      • 10.2.4 Hypertension Drug Product Introduction
      • 10.2.5 Novartis AG Recent Development
    • 10.3 Daiichi - Sankyo
      • 10.3.1 Daiichi - Sankyo Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Hypertension Drug
      • 10.3.4 Hypertension Drug Product Introduction
      • 10.3.5 Daiichi - Sankyo Recent Development
    • 10.4 Pfizer Inc
      • 10.4.1 Pfizer Inc Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Hypertension Drug
      • 10.4.4 Hypertension Drug Product Introduction
      • 10.4.5 Pfizer Inc Recent Development
    • 10.5 Ranbaxy Laboratories Limited
      • 10.5.1 Ranbaxy Laboratories Limited Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Hypertension Drug
      • 10.5.4 Hypertension Drug Product Introduction
      • 10.5.5 Ranbaxy Laboratories Limited Recent Development
    • 10.6 Sanofi S.A
      • 10.6.1 Sanofi S.A Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Hypertension Drug
      • 10.6.4 Hypertension Drug Product Introduction
      • 10.6.5 Sanofi S.A Recent Development
    • 10.7 AstraZeneca Plc
      • 10.7.1 AstraZeneca Plc Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Hypertension Drug
      • 10.7.4 Hypertension Drug Product Introduction
      • 10.7.5 AstraZeneca Plc Recent Development
    • 10.8 Johnson & Johnson Ltd
      • 10.8.1 Johnson & Johnson Ltd Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Hypertension Drug
      • 10.8.4 Hypertension Drug Product Introduction
      • 10.8.5 Johnson & Johnson Ltd Recent Development
    • 10.9 Boehringer Ingelheim
      • 10.9.1 Boehringer Ingelheim Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Hypertension Drug
      • 10.9.4 Hypertension Drug Product Introduction
      • 10.9.5 Boehringer Ingelheim Recent Development
    • 10.10 Merck & Co.
      • 10.10.1 Merck & Co. Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Hypertension Drug
      • 10.10.4 Hypertension Drug Product Introduction
      • 10.10.5 Merck & Co. Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Hypertension Drug Sales Channels
      • 11.2.2 Hypertension Drug Distributors
    • 11.3 Hypertension Drug Customers

    12 Market Forecast

    • 12.1 Global Hypertension Drug Sales and Revenue Forecast 2019-2025
    • 12.2 Global Hypertension Drug Sales Forecast by Type
    • 12.3 Global Hypertension Drug Sales Forecast by Application
    • 12.4 Hypertension Drug Forecast by Regions
      • 12.4.1 Global Hypertension Drug Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Hypertension Drug Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Hypertension or high blood pressure is the condition when blood pressure increases to the unhealthy level. Hypertension is very harmful and it can lead to stroke, heart failure, heart attack and kidney diseases. The main purpose of anti-hypertension drug is to lower and control high blood pressure to protect organs like brain, heart, kidneys.
      Change in lifestyle and elevated stress levels have increased the prevalence of hypertension globally, thereby increasing the demand for hypertension drugs.
      In 2019, the market size of Hypertension Drug is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Hypertension Drug.

      This report studies the global market size of Hypertension Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Hypertension Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Lupin Limited
      Novartis AG
      Daiichi - Sankyo
      Pfizer Inc
      Ranbaxy Laboratories Limited
      Sanofi S.A
      AstraZeneca Plc
      Johnson & Johnson Ltd
      Boehringer Ingelheim
      Merck & Co.

      Market Segment by Product Type
      Calcium Channel Blockers
      Diuretics
      Beta Blockers Vasodilators
      Angiotensin Converting Enzyme Inhibitors
      Alpha Blockers
      Angiotensin Receptor Blockers
      Renin Inhibitors

      Market Segment by Application
      Hospital
      Private clinic
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Hypertension Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Hypertension Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Hypertension Drug are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now